Viewing StudyNCT00225290



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00225290
Status: TERMINATED
Last Update Posted: 2011-10-12
First Post: 2005-09-21

Brief Title: Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
Sponsor: TTY Biopharm
Organization: TTY Biopharm

Organization Data

Organization: TTY Biopharm
Class: INDUSTRY
Study ID: T2202
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: TTY Biopharm
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators